Claret Asset Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.76M | Sell |
20,019
-540
| -3% | -$112K | 0.51% | 44 |
|
|
2026
Q1 | $4.34M | Sell |
20,559
-71
| -0.3% | -$15.3K | 0.52% | 44 |
|
|
2025
Q4 | $4.24M | Sell |
20,630
-499
| -2% | -$93.9K | 0.49% | 44 |
|
|
2025
Q3 | $3.32M | Sell |
21,129
-109
| -0.5% | -$16.8K | 0.4% | 48 |
|
|
2025
Q2 | $3.57M | Buy |
+21,238
| New | +$3.15M | 0.46% | 42 |
|
|
2025
Q1 | – | Sell |
-22,054
| Closed | -$2.81M | – | 45 |
|
|
2024
Q4 | $2.61M | Sell |
22,054
-8
| -0% | -$934 | 0.41% | 45 |
|
|
2024
Q3 | $2.44M | Sell |
22,062
-139
| -0.6% | -$14.5K | 0.4% | 42 |
|
|
2024
Q2 | $2.18M | Buy |
22,201
+364
| +2% | +$37.1K | 0.39% | 44 |
|
|
2024
Q1 | $2.44M | Sell |
21,837
-161
| -0.7% | -$17.4K | 0.41% | 45 |
|
|
2023
Q4 | $2.22M | Sell |
21,998
-39
| -0.2% | -$3.87K | 0.4% | 43 |
|
|
2023
Q3 | $1.91M | Sell |
22,037
-174
| -0.8% | -$15.7K | 0.38% | 43 |
|
|
2023
Q2 | $2.1M | Sell |
22,211
-875
| -4% | -$73.9K | 0.41% | 43 |
|
|
2023
Q1 | $1.74M | Sell |
23,086
-102
| -0.4% | -$7.7K | 0.34% | 48 |
|
|
2022
Q4 | $1.78M | Sell |
23,188
-120
| -0.5% | -$9.12K | 0.39% | 46 |
|
|
2022
Q3 | $1.55M | Sell |
23,308
-114
| -0.5% | -$7.23K | 0.37% | 48 |
|
|
2022
Q2 | $1.22M | Buy |
23,422
+2,305
| +11% | +$131K | 0.26% | 58 |
|
|
2022
Q1 | $1.2M | Sell |
21,117
-260
| -1% | -$13.9K | 0.23% | 59 |
|
|
2021
Q4 | $1.1M | Sell |
21,377
-2,040
| -9% | -$100K | 0.2% | 62 |
|
|
2021
Q3 | $1.16M | Sell |
23,417
-1,324
| -5% | -$71.8K | 0.2% | 64 |
|
|
2021
Q2 | $1.41M | Sell |
24,741
-243
| -1% | -$14.2K | 0.23% | 59 |
|
|
2021
Q1 | $1.52M | Sell |
24,984
-396
| -2% | -$21.9K | 0.28% | 54 |
|
|
2020
Q4 | $1.36M | Sell |
25,380
-2,456
| -9% | -$127K | 0.27% | 56 |
|
|
2020
Q3 | $1.31M | Sell |
27,836
-1,617
| -5% | -$83K | 0.29% | 59 |
|
|
2020
Q2 | $1.54M | Sell |
29,453
-24,388
| -45% | -$1.26M | 0.36% | 52 |
|
|
2020
Q1 | $2.58M | Sell |
53,841
-2,223
| -4% | -$115K | 0.73% | 36 |
|
|
2019
Q4 | $2.84M | Buy |
56,064
+5,729
| +11% | +$296K | 0.54% | 46 |
|
|
2019
Q3 | $2.38M | Buy |
50,335
+4,442
| +10% | +$203K | 0.49% | 53 |
|
|
2019
Q2 | $2.16M | Buy |
45,893
+14,919
| +48% | +$688K | 0.45% | 54 |
|
|
2019
Q1 | $1.49M | Buy |
30,974
+16,906
| +120% | +$847K | 0.3% | 67 |
|
|
2018
Q4 | $627K | Buy |
14,068
+2,967
| +27% | +$155K | 0.14% | 97 |
|
|
2018
Q3 | $599K | Sell |
11,101
-1,186
| -10% | -$60.7K | 0.12% | 98 |
|
|
2018
Q2 | $600K | Buy |
12,287
+3,685
| +43% | +$209K | 0.12% | 98 |
|
|
2018
Q1 | $539K | Sell |
8,602
-95
| -1% | -$6.52K | 0.12% | 100 |
|
|
2017
Q4 | $533K | Buy |
+8,697
| New | +$538K | 0.12% | 101 |
|
Other funds holding CAH
Claret Asset Management's CAH Position: Q2 2026 in Review
Claret Asset Management reduced its Cardinal Health (CAH) stake by 2.6% in Q2 2026, selling an estimated $112K and leaving 20,019 shares worth $4.76M. The position accounts for 0.51% of the portfolio, ranked #44.
Claret Asset Management first reported a position in CAH in Q4 2017 and has held it in 34 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Claret Asset Management held 20,019 shares of Cardinal Health worth $4.76M as of Q2 2026.
- Claret Asset Management sold 540 Cardinal Health shares in Q2 2026, an estimated $112K.
- Cardinal Health made up 0.51% of Claret Asset Management's portfolio in Q2 2026, its #44 holding.
- Claret Asset Management first reported a position in Cardinal Health in Q4 2017 and has held it in 34 quarters since.
- 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.